{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:12:56Z","timestamp":1793153576421,"version":"4.5.0"},"reference-count":32,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Pall Supp Care"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S147895152000005X_sec_a1\"><jats:title>Objective<\/jats:title><jats:p>Symptoms of depression and anxiety are common in neuroendocrine tumor (NET), yet controversy exists over whether serotonin-mediated antidepressants (SAs) are safe in this population. We sought to address this knowledge gap.<\/jats:p><\/jats:sec><jats:sec id=\"S147895152000005X_sec_a2\" sec-type=\"methods\"><jats:title>Method<\/jats:title><jats:p>Following PRISMA guidelines, we conducted a systematic review to identify NET patients who were prescribed SA.<\/jats:p><\/jats:sec><jats:sec id=\"S147895152000005X_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>We identified 15 articles, reporting on 161 unique patients, 72 with carcinoid syndrome (CS) and 89 without. There was substantial agreement between reviewers at the full-text stage (<jats:italic>\u03ba<\/jats:italic> = 0.69). Three of the articles, all with low risk of bias, accounted for most of the cases (149\/161; 93%). Among the 72 NET patients with CS prior to antidepressant usage, CS was exacerbated in 6 cases (8%), only 3 (4%) of whom chose to discontinue the antidepressant. The remaining 89 patients had no prior CS symptoms, and none developed CS following antidepressant usage. Overall, no instances of carcinoid crisis or death were reported.<\/jats:p><\/jats:sec><jats:sec id=\"S147895152000005X_sec_a4\" sec-type=\"conclusions\"><jats:title>Conclusions<\/jats:title><jats:p>We found no evidence for serious adverse outcomes related to SA usage in NET patients. Previous authors have recommended avoiding antidepressants in NET, but our findings do not support those recommendations. Oncologists should nonetheless monitor for symptom exacerbation when prescribing SA to patients with NET.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s147895152000005x","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T09:01:35Z","timestamp":1581325295000},"page":"602-608","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":4,"title":["Must antidepressants be avoided in patients with neuroendocrine tumors? Results of a systematic review"],"prefix":"10.1017","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8717-8845","authenticated-orcid":false,"given":"Elie","family":"Isenberg-Grzeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Matsoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngai","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Reidy-Lagunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesne","family":"Alici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"S147895152000005X_ref20","first-page":"422","article-title":"Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation","volume":"66","author":"Russo","year":"2004","journal-title":"Psychosomatic Medicine"},{"key":"S147895152000005X_ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0589"},{"key":"S147895152000005X_ref19","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e3282fc734b"},{"key":"S147895152000005X_ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"S147895152000005X_ref8","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"S147895152000005X_ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000129342.67174.67"},{"key":"S147895152000005X_ref18","first-page":"1387","article-title":"Sertraline, a selective serotonin reuptake inhibitor, unmasking carcinoid syndrome","volume":"92","author":"Noyer","year":"1997","journal-title":"American Journal of Gastroenterology"},{"key":"S147895152000005X_ref14","first-page":"300","article-title":"Psychiatric considerations in the oncology setting","volume":"65","author":"Mehta","year":"2015","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"S147895152000005X_ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-9861.2004.tb00093.x"},{"key":"S147895152000005X_ref23","doi-asserted-by":"publisher","DOI":"10.3928\/00485713-20160120-01"},{"key":"S147895152000005X_ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2017-110853"},{"key":"S147895152000005X_ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3181ebb2a5"},{"key":"S147895152000005X_ref11","first-page":"251","article-title":"Malignant hyperthermia in a morbidly obese patient depletes community dantrolene resources: A case report","volume":"9","author":"Magistris","year":"2017","journal-title":"Anesthesia and Analgesia Case Reports"},{"key":"S147895152000005X_ref26","first-page":"1245","article-title":"Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: A meta-analysis","volume":"159","author":"Trindade","year":"1998","journal-title":"CMAJ"},{"key":"S147895152000005X_ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000080737"},{"key":"S147895152000005X_ref30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"S147895152000005X_ref21","first-page":"E1","article-title":"Atypical carcinoid of the larynx and potential complications of the carcinoid syndrome: A case report","volume":"88","author":"Seshamani","year":"2009","journal-title":"Ear, Nose and Throat Journal"},{"key":"S147895152000005X_ref29","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.46.4.370"},{"key":"S147895152000005X_ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29099"},{"key":"S147895152000005X_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.03.010"},{"key":"S147895152000005X_ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197307000-00013"},{"key":"S147895152000005X_ref9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/02841860152703445","article-title":"Health-related quality of life, anxiety and depression in patients with midgut carcinoid tumours","volume":"40","author":"Larsson","year":"2001","journal-title":"Acta Oncologica"},{"key":"S147895152000005X_ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000354637"},{"key":"S147895152000005X_ref17","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2016.1182210"},{"key":"S147895152000005X_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.04.010"},{"key":"S147895152000005X_ref28","unstructured":"Wells, G , Shea, B , O'Connell, D , (2019) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Retrieved from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"S147895152000005X_ref13","first-page":"S431","article-title":"All that flushes is notmenopause: How to flesh out flushing","volume":"32","author":"Mehra","year":"2017","journal-title":"Journal of General Internal Medicine"},{"key":"S147895152000005X_ref22","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30633"},{"key":"S147895152000005X_ref24","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.46.1.88-a"},{"key":"S147895152000005X_ref31","doi-asserted-by":"publisher","DOI":"10.5152\/balkanmedj.2012.081"},{"key":"S147895152000005X_ref32","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-2-123"},{"key":"S147895152000005X_ref1","first-page":"106","article-title":"The case study masterclass. Case 20: Symptom control in a patient with carcinoid tumour","volume":"12","author":"Bajwah","year":"2005","journal-title":"European Journal of Palliative Care"}],"container-title":["Palliative and Supportive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S147895152000005X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T20:30:20Z","timestamp":1607632220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S147895152000005X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S147895152000005X"],"URL":"https:\/\/doi.org\/10.1017\/s147895152000005x","relation":{},"ISSN":["1478-9515","1478-9523"],"issn-type":[{"value":"1478-9515","type":"print"},{"value":"1478-9523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2020","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}